The low density lipoprotein (LDL) receptor has been purified to homogeneity from rabbit liver by a combination of DEAE-Sephacel chromatography, LDL-Sepharose 4B chromatography and preparative SDS/polyacrylamide-gel electrophoresis. The receptor protein had a pI of 4.45 and an Mr of 120 x 103-125 x 103 in SDS gels under non-reducing conditions. Incubation of the LDL receptor with neuraminidase decreased its Mr to 105 x 103-l 10 X 103 and increased its pI from 4.45 to 5.25. The purified receptor exhibited all the properties of the membrane-bound receptor including Ca2l-dependent binding of rabbit and human LDL but not of methylated LDL or high density lipoprotein. The amount of LDL receptor present in rabbit liver was measured by a quantitative blotting procedure employing a newly developed rat anti-receptor monoclonal antibody. The affinity and specificity of this monoclonal antibody allowed the quantification of the LDL receptor in detergent extracts of liver homogenate, thus eliminating the loss of receptor associated with the preparation of membrane fractions prior to receptor assay. Livers from adult female New Zealand White rabbits contained 149+ 13 ng of LDL receptor/mg of liver protein. Administration of pharmacological doses of 17a-ethinyloestradiol raised the concentration of LDL receptor in liver to 312 + 25 ng/mg of liver protein.
INTRODUCTION
It is now well established from clearance studies carried out in vivo that the majority of serum LDL is catabolized through the LDL receptor pathway (Pittman et al., 1979; Mahley et al., 1980; Slater et al., 1980; Pittman et al., 1982; Carew et al., 1982; Kesaniemi et al., 1983; Steinbrecher et al., 1983; Spady et al., 1983) . Studies in several species, including man, have shown that this process occurs predominantly in the liver (Pittman et al., 1979; Slater et al., 1980; Carew et al., 1982; Pittman et al., 1982; Spady et al., 1983; Starzl et al., 1984) .
Several lines of evidence suggest that the activity of the LDL receptor in liver is important in controlling the level of circulating LDL and, therefore, much work is now being directed to study the factors and mechanisms which regulate the expression of the receptor in this tissue. Such studies, however, require suitable assays for the receptor protein in vitro and able to show if the changes in receptor activity measured in the whole animal by LDL clearance are controlled at the protein and, ultimately, at the DNA level.
Binding of 125I-LDL to liver membranes has been extensively used as an assay for the liver receptor carried out in vitro Hui et al., 1981; Kita et al., 1981; Harders-Spengel et al., 1982) . However, these assays frequently produce variable results and only a small fraction of the binding of 125I-LDL to liver membranes is due to the LDL receptor. More recently, binding of LDL to the LDL receptor separated by electrophoresis and transferred to nitrocellulose has been successfully used for the detection of the LDL receptor in several tissues (Daniel et al., 1983; Dresel et al., 1984) including liver (Kroon et al., 1984; Wade et al., 1986) . A limitation of both these assays, however, is that they first require isolation of liver membranes, a step which is associated with a variable and significant loss of receptor (see below).
We report here the purification to homogeneity of the LDL receptor from rabbit liver and the quantification of the receptor protein in whole tissue homogenates. This has been made possible by the availability of pure receptor protein and a newly developed anti-receptor monoclonal antibody which binds with high affinity and specificity detergent-solubilized LDL receptor. The ability to measure the level of receptor protein and mRNA (Ma et al., 1986) in liver and extra-hepatic tissues may help in the understanding of mechanisms which regulate the expression of the LDL receptor at the tissue level and especially in liver.
MATERIALS AND METHODS Animals
Male and female (2.0-2.5 kg) New Zealand White rabbits were used. Treatment with 17a-ethinyloestradiol (Sigma, E 4876) was carried out subcutaneously for 7 days at a dose of 5 mg/kg as described by Kovanen et al. (1979) .
Liver fractionation
Rabbits were killed by intravenous injection of sodium pentabarbitone (150 mg/kg) and the livers were isolated and washed in ice-cold 0.05 M-Tris/maleate/0. 15 M-NaCI/0.002 M-CaCl2/0.001 M-PMSF, pH 6.5 (homogenization buffer). All subsequent operations were performed at 4 'C. Liver tissue was homogenized with a Polytron homogenizer (maximum setting, 15 + 15 s) at a concentration of 200 g of wet tissue per litre. The homogenate was centrifuged at 1000 g for O min and the supernatant centrifuged at 14000 g for 10 min. The 14000 g supernatant was centrifuged at 104000 g for 60 min in a Beckman 55 Ti rotor. The < 1000 g, 1000-14000 g, and 14000-104000 g fractions were resuspended in homogenization buffer with a Potter homogenizer (3-4 strokes) and frozen in liquid N2. In several experiments 14000-104000g membranes were resuspended in 0.01 M-Tris/maleate/0.002 M-CaCl2/ 0.001 M-PMSF, pH 6.5, and adjusted to 2.1 M-sucrose with 3.19 M-sucrose in 0.01 M Tris/maleate/0.002 MCaCl2/0.001 M-PMSF, pH 6.5, at a protein concentration of approx. 5 mg/ml. Membrane (11 ml) suspension in 2.1 M-sucrose was overlayered with 16 ml of 1.15 Msucrose and 11 ml of 0.25 M-sucrose. Tubes were centrifuged for 4 h at 75000 g in Beckman SW28 rotor at 4°C. Two major membrane subfractions were separated at the 2.1/1.15M-sucrose interface (heavy subfraction) and at the 1.15/0.25 M-sucrose interface (light subfraction). These were collected, diluted to 0.25 M-sucrose with 0.01 M-Tris/maleate/0.002 M-CaCl2/0.00 1 M-PMSF, pH 6.5, recovered by ultracentrifugation at 104000 g for 60 min in a 55 Ti rotor and processed as for the other membrane fractions.
Purification of the LDL receptor
Purification of the LDL receptor was carried out from the 14000-104000 g membranes using a combination of DEAE-Sephacel chromatography, LDL -Sepharose 4B chromatography and preparative SDS/polyacrylamidegel electrophoresis. Membrane proteins were solubilized as described by Schneider et al. (1982) and the detergent extract in 0.05 M-Tris/maleate/0.05 M-NaCl /0.002 MCaCl2/0.001 M-PMSF/Triton X-100 (10 g/l), pH 6.0, was loaded on a column packed with DEAE-Sephacel (Pharmacia, Final purification of the LDL receptor was carried out by preparative electrophoresis in SDS/polyacrylamide gels according to Walker et al. (1982) . Slab gels (1.5 mm x 160 mm) were loaded with 52-209,ug of protein (LDL-Sepharose 4B fraction). The LDL receptor band was cut and the receptor electro-eluted and collected in a dialysis tubing (cut-off point 10-14 kDa, Visking) as described by Walker et al. (1982) . Purified receptor was dialysed for 24 h against 0.05 M-Tris/HCl/0.05 M-NaCl, pH 8.0 and stored at -70 'C.
Assays of LDL receptor
Binding of 125I-LDL to liver membranes was carried out basically as described by Kovanen et al. (1979) .
Membrane protein (100,ug) was used for each assay in 0.05 M-Tris/HCl/0.1 M-NaCI/BSA (20 g/l), pH 7.5, and incubated with 125I-LDL for 60 min in ice at a concentration of S ,ag of 'l25-LDL/ml. Membrane-bound 125I-LDL was separated from free 125I-LDL by a 5 min centrifugation in a Beckman Airfuge ultracentrifuge on a cushion of foetal bovine serum as described in Kovanen et al. (1979) . For each membrane sample three tubes were incubated in the presence of 0.001 M-CaCl2 (total binding) and three tubes were incubated in 0.005 M-EDTA (Ca2+-independent binding). The difference between the total binding and the Ca2"-independent binding of 125I-LDL was regarded as the binding of '25I-LDL to the LDL receptor.
Antibody and lipoprotein blots of LDL receptor were carried out after SDS/polyacrylamide-gel electrophoresis (Laemmli, 1970) and transfer to nitrocellulose (Schleicher and Schuell, BA 85). Transfer was for 1 h at 0.5 A and 8-10 'C. Nitrocellulose was first blocked with 25 g of BSA/litre in TBS (blocking buffer) at 37 'C for 30 min.
All subsequent incubations were carried out at room temperature and were in 25 g of BSA/litre in TBS plus 0.001 M-CaC12 unless otherwise indicated. For antibody blots nitrocellulose was incubated with anti-receptor monoclonal antibodies in blocking buffer followed by incubation with enzyme-conjugated second antibody and enzyme substrate. For LDL blots the paper was incubated with affinity-purified anti-LDL polyclonal or monoclonal IgG followed by incubation with enzymeconjugated second antibody and enzyme substrate as indicated in the legends to Figs. 2 and 3. Between each incubation the paper was washed three times for 10 min with 1 g of Tween 20/litre in TBS (antibody blots) or with 2.5 g of BSA/litre in TBS (LDL blots).
A detergent-based double antibody assay for the LDL receptor was employed in some experiments. Flexible vinyl microtitre plates were coated overnight at room temperature with 5 jtg of anti-receptor monoclonal antibody/well in 0.05 ml of 0.05 M-Na2CO3/0.001 MNaN3, pH 9.6. Plates were washed with TBS, blocked with 50,l of BSA (25 g/litre)/well in 0.05 M-Na2CO3 for 1 h at 37 'C and incubated for 3 h at room temperature with either purified LDL receptor or with different amounts of detergent extract of liver homogenate in 0.05 M-Tris/HCl/0.05 M-NaCl/0.002 M-CaCl2/0.001 M-PMSF, 10 g/l Triton X-100, pH 6.8. Plates were washed three times with 1 g of Tween 20/litre in TBS, 250000 c.p.m. 125I-MAC188 (see below) were added to each well and incubation was continued for 3 h. Plates were washed as above, air-dried and individual wells cut and counted. Anti-LDL receptor monoclonal antibodies Three rat monoclonal antibodies raised against purified rabbit liver LDL receptor were used in this study. They (Galfre et al., 1979) . A detailed characterization of these antibodies is to be reported separately.
Serum lipoproteins LDL (1.019-1.063 g/ml) and HDL (1.063-1.21 g/ml) were isolated from rabbit and human serum by preparative ultracentrifugation in a 55 Ti rotor at 50000 rev./min for 16 h (LDL) or 24 h (HDL) at 4 'C. Lipoproteins were purified by recentrifugation at the same density, dialysed at 4 'C against 0.01 M-Tris/HCl/ 0.15 M-NaCl/0.001 M-EDTA, pH 7.4, and stored at 4 'C after filtration on 0.2 ,um filters. LDL was conjugated to CNBr-activated Sepharose 4B (Pharmacia 17-04030-01) according to the instructions of the manufacturer using 25 mg of LDL protein/g of gel. Coupling efficiency ranged from 780 to 930. Reductive methylation of LDL was carried out according to Weisgraber et al. (1978) . lodination of LDL (444-872 c.p.m./ng) with carrier-free 1251 (Amersham, IMS.30) was performed according to a modification of the procedure of Marchalonis (1969) .
Other assays
Protein was assayed with a modification of the Lowry procedure (Markwell et al., 1978) . Samples containing 10 g of Triton X-100/litre or 0.03 M-n-octyl-,8-Dglucopyranoside were diluted 10-100 times before assay. Samples eluted from the LDL-Sepharose 4B in 0.05 MTris/maleate/0.0035 M-suramin, pH 6.0, were assayed for protein after precipitation with trichloroacetic acid (50 g/l) in the presence of sodium deoxycholate (Schneider et al., 1982) . Apolipoproteins B and A-I in rabbit serum were measured by electroimmunoassay using sheep anti-sera raised against LDL (T 587) and apolipoprotein A-I (T 627).
RESULTS
LDL receptor specific activity in liver is 5-10 times lower than in adrenal glands Huettinger et al., 1984) , the tissue from which LDL receptor has previously been purified (Schneider et al., 1982) . Since administration of 17a-ethinyloestradiol to rats and rabbits (Kroon et al., 1984; Ma et al., 1986 ) was known to increase the expression of LDL receptor in liver, the hormone was administered for 7 days to adult rabbits in order to increase receptor specific activity in this tissue. The treatment produced a 240 reduction in liver weight and a 3.5-fold increase of the liver receptor as measured in the membrane assay (Table 1) . These changes were associated with a fall in plasma apo B (49 0%) and a less-pronounced reduction in serum apolipoprotein A-I (15 %). The increase in liver receptor produced by the hormone was less dramatic than the one obtained in other studies Ma et al., 1986 ) but represented, nevertheless, a significant increase in LDL receptor specific activity in liver membranes.
To optimize the purifications of the LDL receptor from the liver of rabbits treated with 17a-ethinyloestradiol the distribution of the receptor among several subcellular fractions was studied and results are shown in Table 2 . The 14000-104000 g membrane fraction contained approximately half the amount of LDL receptor present in liver homogenate. Subfractionation of this membrane fraction by sucrose density-gradient ultracentrifugation revealed that the highest LDL receptor activity was associated with the light membranes ( Table  2 ). This subfraction is known to be enriched in plasma sinusoidal membranes (Evans, 1978) suggesting that the LDL receptor is preferentially localized on the sinusoidal side of the plasma membrane of the hepatocytes. A similar conclusion has been reached by electron microscopic studies of LDL uptake in the liver of rats treated with oestradiol (Chao et al., 1981; Handley et al., 1981) . Although the light subfraction of the 14000-104000 g membranes appeared to be the best source of LDL receptor in liver, this fraction was not chosen for the purification of the receptor because of the reduced amounts of membranes which could be processed at each time on the sucrose gradient and the low recovery of receptor ( Table 2 ). The 14000-104 000 g fraction was finally used for the purification of the receptor protein.
Partial purification of the LDL receptor from liver was obtained by the DEAE and LDL-Sepharose 4B procedure of Schneider et al. (1982) . Fig. 1 shows the elution profile of rabbit microsomal proteins eluted from a DEAE-Sephacel column with a gradient of NaCl in the presence of micellar concentrations of n-octyl-/J-Dglucopyranoside. The receptor eluted from the colum with a peak at 0.15 M-NaCl. The DEAE-Sephacel fraction (Fig. 1, bar) was subsequently applied on an LDLSepharose 4B column and the receptor eluted with a buffer containing 0.0035 M-suramin. While this procedure allowed purification to homogeneity of the LD lipoprotein receptor from adrenal membranes (Schneider et al., 1982) , it yielded preparations of liver receptor containing variable amounts of other proteins. Under optimal conditions, the fraction eluted from LDLSepharose 4B contained the LDL receptor and two Vol. 253 Table 2 . Distribution of the LDL receptor among subceUlular fractions in rabbit liver Liver homogenate was prepared from male rabbits treated with 17a-ethinyloestradiol and membrane fractions were prepared at 1000 g, 14000 g and 104000 g. The 14000-104000 g membranes were subfractionated by sucrose-density ultracentrifugation into a heavy subfraction (2. Fig. 1 . DEAE-Sephacel chromatography of 14000-104000 g soluble membrane proteins Membrane proteins (14000-104000 g; 1.4 g) in 630 ml of 0.05 M-Tris/maleate/0.05 M-NaCI/0.002 M-CaCI2/ 0.001 M-PMSF, 10 g Triton X-100/litre, pH 6.0 (DEAE buffer A), were loaded on a 2.5 cm x 7.5 cm DEAESephacel column at 60 ml/h. Unbound proteins (1.2 g) were collected as a single fraction and the column was washed with 75 ml of DEAE buffer A followed by 75 ml of Final purification of the receptor was achieved by preparative SDS/polyacrylamide-gel electrophoresis of the LDL-Sepharose 4B fraction followed by electroelution. Fig. 2 shows, on the left, Coomassie-stained SDS gels of the Triton X-100 extract of the 14000-104000 membranes (lane 1), the DEAE-Sephacel, unbound fraction (lane 2), the DEAE-Sephacel fraction (lane 3) and LDL receptor finally purified by LDLSepharose 4B followed by preparative gel electrophoresis (lane 4). The final yield of receptor was 20-25 ng/mg of liver protein. The Mr of the receptor protein was 120 x 103-125 x 103 in non-reducing gels (Fig. 2) and increased to 135 x 103-140 x 103 in reducing gels (results not shown). LDL blots of the same fractions are shown in Fig. 2 on the right. It is apparent that both the starting membrane extract and the DEAE-Sephacel fraction (lanes 1 and 3), in addition to the LDL receptor, contain a second LDL-binding protein to Mr of 270 x 103. This protein has been observed by others (Hoeg et al., 1986; Wade et al., 1986) in LDL blots of liver membranes and Hoeg et al. (1986) have suggested that this protein is a liver-specific form of the LDL receptor. However, in our hands, the binding of LDL to this protein was not Ca2+-dependent and the protein was not recognized by antireceptor monoclonal antibody. Therefore, no further attempts were made to establish the identity of this protein.
Treatment of purified LDL receptor with neuraminidase changed both the Mr and the pI of the LDL receptor. The Mr shifted from 125 x 103 to 11Ox 103 whereas the pI was raised from 4.45 to 5.25 (results not shown). Thus the rabbit LDL receptor, like the bovine one (Schneider et al., 1982) , contained sialic acid which accounted, in part, for its low pL Fig. 3 . Gel was run under non-reducing conditions. The mobility of Mr markers is indicated. Right, LDL blots of the same samples. Proteins were transferred to nitrocellulose and the paper was blocked. Blots were then incubated with rabbit LDL (5 ,ug/ml), anti-rabbit LDL monoclonal IgG (MAC 23 at 5 ,tg/ml) and alkaline phosphatase-conjugated second antibody (Sigma A9654, diluted 1/1000). Alkaline phosphatase was detected with the substrate described by Blake et al. (1984) . used both to immobilize and probe the receptor the amount of 125I-MAC188 bound was small and up to 100 ng of LDL receptor/well were necessary to increase the counts at approximately twice the background. This indicated that the epitope recognized by MAC188 was not a multiple epitope. When MAC189 was used to immobilize the receptor and MAC188 used to probe the receptor, a linear relation between the amount of LDL receptor per well and the amount of 125I-MAC188 bound was found in the range of 5-500 ng/well (results not shown). Thus, the double antibody solid-phase immunoassay using MAC189 and MAC188 was used to try to quantify the LDL receptor in detergent extracts of liver homogenate but failed to produce positive results. Three problems emerged with the tissue extracts: (1) the amount of '25I-MAC188 bound was very low (< 200 c.p.m. of 125I-MACl88 bound/well using the detergent extract from up to 250 ,tg of protein); (2) (Fig. 4, left) Liver homogenates were prepared from eight female rabbits (2.0-2.5 kg body weight). Four rabbits were treated with 17ac-ethinyloestradiol for 7 days at 5 mg/kg. Homogenates were prepared as described in the Materials and methods section except that 0.05 M-Tris/HCl/0. 15 MNaCl/0.002 M-CaCl2/0.001 M-PMSF, pH 6.8, was used as homogenization buffer. Liver proteins were solubilized with Triton X-100 (10 g/l final concn.) and the detergent extracts from 500 ,tg of liver proteins were loaded on SDS gel (75 g/l), transferred to nitrocellulose and incubated with monoclonal antibody MAC 188 (5 4ag/ml) followed by alkaline phosphatase-conjugated anti-(rat IgG) serum and alkaline phosphatase substrate. (Kroon et al., 1984; Wade et al., 1986) . In similar ligand blotting experiments the Mr of the bovine adrenal receptor was found to be 130 x 103 (Daniel et al., 1983) , the Mr of the rat liver receptor was either 145 x 103 (Kroon et al., 1984; Wade et al., 1986) or 135 x 103 (Cooper et al., 1987) and that of the dog liver receptor was 147 x 103 and that human liver biopsies contained 20.2 + 1.6 ng of LDL receptor/mg of liver membrane protein ). This figure is lower than the one obtained in the present study (149 + 13 ng/mg of liver protein) suggesting that the receptor content of rabbit liver is much higher than that of human liver.
The major disadvantage of the receptor assay reported in this study, compared with the double antibody assay in microtitre plates, is the limited number of samples which can be processed at one time. Typically, we load purified receptor on to four lanes and up to ten samples onto each gel. One advantage of the blot assay, however, is that the LDL lipoprotein receptor precursor (the faint band with an Mr of 90 x 103 in Fig. 4 ) can be quantified, if required, separately from the mature form of the receptor. This can be easily achieved (at least with liver or spleen tissues) by loading the detergent extract from 1 mg of protein (results not shown).
The assay for the LDL receptor in liver homogenate which we have developed may prove useful in the study of the factors which regulate the expression of the LDL receptor in liver. Evidence is available from animal studies that dietary lipids suppress the expression of receptor in liver (Kovanen et al., 1981; Mahley et al., 1981; Spady & Dietschy, 1985) and that suppression of the liver receptor may be partially reversed by hormones (Kushwaha & Hazzard, 1981) and drugs (Chao et al., 1983) . Administration of 17a-ethinyloestradiol to the rabbit increases the amount of mRNA for the receptor (Ma et al., 1986) , the binding of '25I-LDL to liver membranes (Table 2 ) and the amount of receptor protein in the tissue (Fig. 4) 
